Literature DB >> 2820710

Structure and expression of human thrombomodulin, a thrombin receptor on endothelium acting as a cofactor for protein C activation.

K Suzuki1, H Kusumoto, Y Deyashiki, J Nishioka, I Maruyama, M Zushi, S Kawahara, G Honda, S Yamamoto, S Horiguchi.   

Abstract

We have deduced the entire 575-amino acid sequence of the human thrombomodulin precursor from cDNA clones. The precursor starts with an 18-residue signal peptide domain, followed by the NH2-terminal domain, a domain with six epidermal growth factor-like structures, an O-glycosylation site-rich domain, a 24-residue transmembrane domain and a cytoplasmic domain. Simian COS cells transfected with the expression vector pSV2 containing thrombomodulin cDNA synthesized immunoreactive and functionally active thrombomodulin.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2820710      PMCID: PMC553573          DOI: 10.1002/j.1460-2075.1987.tb02448.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  45 in total

1.  Cultivation of arterial endothelial cells from human umbilical cord.

Authors:  Y Mano; Y Sawasaki; K Takahashi; T Goto
Journal:  Experientia       Date:  1983-10-15

2.  Domain map of the LDL receptor: sequence homology with the epidermal growth factor precursor.

Authors:  D W Russell; W J Schneider; T Yamamoto; K L Luskey; M S Brown; J L Goldstein
Journal:  Cell       Date:  1984-06       Impact factor: 41.582

3.  Inactivation of human coagulation factor V by activated protein C.

Authors:  K Suzuki; J Stenflo; B Dahlbäck; B Teodorsson
Journal:  J Biol Chem       Date:  1983-02-10       Impact factor: 5.157

4.  Establishing homologies in protein sequences.

Authors:  M O Dayhoff; W C Barker; L T Hunt
Journal:  Methods Enzymol       Date:  1983       Impact factor: 1.600

5.  Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells.

Authors:  A Ullrich; L Coussens; J S Hayflick; T J Dull; A Gray; A W Tam; J Lee; Y Yarden; T A Libermann; J Schlessinger
Journal:  Nature       Date:  1984 May 31-Jun 6       Impact factor: 49.962

6.  Complex formation between thrombin and thrombomodulin inhibits both thrombin-catalyzed fibrin formation and factor V activation.

Authors:  C T Esmon; N L Esmon; K W Harris
Journal:  J Biol Chem       Date:  1982-07-25       Impact factor: 5.157

7.  Isolation and characterization of thrombomodulin from human placenta.

Authors:  H H Salem; I Maruyama; H Ishii; P W Majerus
Journal:  J Biol Chem       Date:  1984-10-10       Impact factor: 5.157

8.  The human LDL receptor: a cysteine-rich protein with multiple Alu sequences in its mRNA.

Authors:  T Yamamoto; C G Davis; M S Brown; W J Schneider; M L Casey; J L Goldstein; D W Russell
Journal:  Cell       Date:  1984-11       Impact factor: 41.582

9.  Thrombomodulin blocks the ability of thrombin to activate platelets.

Authors:  N L Esmon; R C Carroll; C T Esmon
Journal:  J Biol Chem       Date:  1983-10-25       Impact factor: 5.157

10.  Nucleotide sequence of epidermal growth factor cDNA predicts a 128,000-molecular weight protein precursor.

Authors:  A Gray; T J Dull; A Ullrich
Journal:  Nature       Date:  1983 Jun 23-29       Impact factor: 49.962

View more
  64 in total

1.  A case of thrombomodulin mutation causing defective thrombin binding with absence of protein C and TAFI activation.

Authors:  Masahiko Okada; Norio Tominaga; Goichi Honda; Junji Nishioka; Nobuyuki Akita; Tatsuya Hayashi; Koji Suzuki; Hiroyuki Moriuchi
Journal:  Blood Adv       Date:  2020-06-23

2.  Up-regulation of thrombomodulin by activation of histamine H1-receptors in human umbilical-vein endothelial cells in vitro.

Authors:  K Hirokawa; N Aoki
Journal:  Biochem J       Date:  1991-06-15       Impact factor: 3.857

3.  Structural resiliency of an EGF-like subdomain bound to its target protein, thrombin.

Authors:  R Hrabal; E A Komives; F Ni
Journal:  Protein Sci       Date:  1996-02       Impact factor: 6.725

4.  Stability of the thrombin-thrombomodulin complex on the surface of endothelial cells from human saphenous vein or from the cell line EA.hy 926.

Authors:  A Beretz; J M Freyssinet; J Gauchy; D A Schmitt; C Klein-Soyer; C J Edgell; J P Cazenave
Journal:  Biochem J       Date:  1989-04-01       Impact factor: 3.857

5.  Angiogenic Factors Correlate with T Cell Immune Reconstitution and Clinical Outcomes after Double-Unit Umbilical Cord Blood Transplantation in Adults.

Authors:  Ioannis Politikos; Haesook T Kim; Theodoros Karantanos; Julia Brown; Sean McDonough; Lequn Li; Corey Cutler; Joseph H Antin; Karen K Ballen; Jerome Ritz; Vassiliki A Boussiotis
Journal:  Biol Blood Marrow Transplant       Date:  2016-10-21       Impact factor: 5.742

Review 6.  Pathogenesis of disseminated intravascular coagulation in patients with acute promyelocytic leukemia, and its treatment using recombinant human soluble thrombomodulin.

Authors:  Takayuki Ikezoe
Journal:  Int J Hematol       Date:  2013-11-12       Impact factor: 2.490

Review 7.  Novel antithrombotic drugs in development.

Authors:  M Verstraete; P Zoldhelyi
Journal:  Drugs       Date:  1995-06       Impact factor: 9.546

8.  Thrombin-thrombomodulin interaction: energetics and potential role of water as an allosteric effector.

Authors:  R De Cristofaro; M Picozzi; E De Candia; B Rocca; R Landolfi
Journal:  Biochem J       Date:  1995-08-15       Impact factor: 3.857

9.  A biologically active surface enzyme assembly that attenuates thrombus formation.

Authors:  Zheng Qu; Sharmila Muthukrishnan; Murali K Urlam; Carolyn A Haller; Sumanas W Jordan; Vivek A Kumar; Ulla M Marzec; Yaseen Elkasabi; Joerg Lahann; Stephen R Hanson; Elliot L Chaikof
Journal:  Adv Funct Mater       Date:  2011-09-26       Impact factor: 18.808

10.  Thrombomodulin expression in malignant pleural mesothelioma and pulmonary adenocarcinoma.

Authors:  C L Collins; N G Ordonez; R Schaefer; C D Cook; S S Xie; J Granger; P L Hsu; L Fink; S M Hsu
Journal:  Am J Pathol       Date:  1992-10       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.